TrialJournal of acquired immune deficiency syndromes (1999)2016

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial.

Peter J Kuebler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.